| Application no. and date | 17757069.4 (espacenet) (Federated) (European Patent Register), 20170221 | | Patent/reg. no. and date | DK/EP 3377176, 20211020 | | Publication date | 20180926 | | Priority no. and date | US 201662298555 P, 20160223 | | EP pub. no. and date |
EP 3377176 20180926 | | Effective date | | | Applicant/owner | Morgandane Scientific, LLC, 2012 Seadrift Drive
Corona Del Mar, CA 92625, US | | Applicant ref. no. | 1616805 | | Inventor | CHOW, Christina, 325 23rd Ave E
Seattle
Washington 98112, US,
SRINIVASAN, Sundar, 2012 Seadrift Drive
Corona Del Mar, CA 92625, US,
PATEL, Maulik, 1209 Oak Grove Avenue
Unit 101
Burlingame, CA 94010, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/277 (2006.01) , A61K 31/5377 (2006.01) , A61P 7/02 (2006.01) , A61P 9/12 (2006.01) | | Title | FREMGANGSMÅDE TIL BEHANDLING AF PATIENTER, DER FÅR ADMINISTRERET RIVAROXABAN SAMMEN MED VERAPAMIL | | Int. application no. | US2017018727 | | Int. publication no. | WO2017147074 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
